{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:53:50Z","timestamp":1794455630404,"version":"4.9.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2023\/49\/B\/NZ7\/03456"],"award-info":[{"award-number":["2023\/49\/B\/NZ7\/03456"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["801133"],"award-info":[{"award-number":["801133"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.drudis.2024.104056","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T11:46:16Z","timestamp":1717587976000},"page":"104056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Targeting shelterin proteins for cancer therapy"],"prefix":"10.1016","volume":"29","author":[{"given":"Wioletta","family":"Brankiewicz-Kopcinska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Kallingal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslaw","family":"Krzemieniecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6795-7515","authenticated-orcid":false,"given":"Maciej","family":"Baginski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2024.104056_b0005","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2022","journal-title":"Genes Dis"},{"key":"10.1016\/j.drudis.2024.104056_b0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.drudis.2024.104056_b0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1582-4934.2010.01253.x","article-title":"Targeting the telomere and shelterin complex for cancer therapy: current views and future perspectives","volume":"15","author":"Bilsland","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.drudis.2024.104056_b0020","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1083\/jcb.201610111","article-title":"Telomere-driven diseases and telomere-targeting therapies","volume":"216","author":"Mart\u00ednez","year":"2017","journal-title":"J Cell Biol"},{"key":"10.1016\/j.drudis.2024.104056_b0025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2147\/CIA.S256425","article-title":"Shelterin complex at telomeres: implications in ageing","volume":"15","author":"Mir","year":"2020","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.drudis.2024.104056_b0030","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1101\/gad.1346005","article-title":"Shelterin: the protein complex that shapes and safeguards human telomeres","volume":"19","author":"de Lange","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.drudis.2024.104056_b0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-genet-032918-021921","article-title":"Shelterin-mediated telomere protection","volume":"52","author":"de Lange","year":"2018","journal-title":"Annu Rev of Genet"},{"key":"10.1016\/j.drudis.2024.104056_b0040","doi-asserted-by":"crossref","first-page":"51338","DOI":"10.1074\/jbc.M409293200","article-title":"Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins","volume":"279","author":"Liu","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2024.104056_b0045","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1128\/MCB.00603-07","article-title":"Telomere maintenance through spatial control of telomeric proteins","volume":"27","author":"Chen","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.drudis.2024.104056_b0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/ijms23010523","article-title":"ATM: functions of ATM kinase and its relevance to hereditary tumors","volume":"23","author":"Ueno","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.104056_b0055","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrm.2017.67","article-title":"The essential kinase ATR: ensuring faithful duplication of a challenging genome","volume":"18","author":"Saldivar","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2024.104056_b0060","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.7314\/APJCP.2015.16.8.3085","article-title":"Shelterin proteins and cancer","volume":"16","author":"Patel","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.drudis.2024.104056_b0065","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.3390\/ijms20133186","article-title":"Quantitative biology of human shelterin and telomerase: searching for the weakest point","volume":"20","author":"Veverka","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.104056_b0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-biochem-080320-110356","article-title":"Repair of DNA double-strand breaks by the non-homologous end joining pathway","volume":"90","author":"Stinson","year":"2021","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.drudis.2024.104056_b0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.molcel.2007.03.023","article-title":"A RAP1\/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends","volume":"26","author":"Bae","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.drudis.2024.104056_b0080","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1128\/MCB.00286-09","article-title":"POT1 association with TRF2 regulates telomere length","volume":"29","author":"Kendellen","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.drudis.2024.104056_b0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/6.1.69","article-title":"Comparison of the human and mouse genes encoding the telomeric protein, TRF1: chromosomal localization, expression and conserved protein domains","volume":"6","author":"Broccoli","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.drudis.2024.104056_b0090","doi-asserted-by":"crossref","first-page":"37486","DOI":"10.1074\/jbc.M608778200","article-title":"The basic domain of TRF2 directs binding to DNA junctions irrespective of the presence of TTAGGG repeats","volume":"281","author":"Fouch\u00e9","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2024.104056_b0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.embor.7400314","article-title":"How the human telomeric proteins TRF1 and TRF2 recognize telomeric DNA: a view from high-resolution crystal structures","volume":"6","author":"Court","year":"2005","journal-title":"EMBO Rep"},{"key":"10.1016\/j.drudis.2024.104056_b0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.abb.2018.02.005","article-title":"The structurally similar TRFH domain of TRF1 and TRF2 dimers shows distinct behaviour towards TIN2","volume":"642","author":"Kalathiya","year":"2018","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.drudis.2024.104056_b0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1097-2765(01)00321-5","article-title":"Structure of the TRFH dimerization domain of the human telomeric proteins TRF1 and TRF2","volume":"8","author":"Fairall","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.drudis.2024.104056_b0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1110\/ps.04983705","article-title":"Comparison between TRF2 and TRF1 of their telomeric DNA-bound structures and DNA-binding activities","volume":"14","author":"Hanaoka","year":"2005","journal-title":"Protein Sci"},{"key":"10.1016\/j.drudis.2024.104056_b0115","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1126\/science.1151804","article-title":"A shared docking motif in TRF1 and TRF2 used for differential recruitment of telomeric proteins","volume":"319","author":"Chen","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.drudis.2024.104056_b0120","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb.1575","article-title":"TRF2 functions as a protein hub and regulates telomere maintenance by recognizing specific peptide motifs","volume":"16","author":"Kim","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.drudis.2024.104056_b0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1515\/hsz-2018-0368","article-title":"The structural biology of the shelterin complex","volume":"400","author":"Chen","year":"2019","journal-title":"Biol Chem"},{"key":"10.1016\/j.drudis.2024.104056_b0130","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.cub.2006.05.022","article-title":"Apollo, an Artemis-related nuclease, interacts with TRF2 and protects human telomeres in S phase","volume":"16","author":"van Overbeek","year":"2006","journal-title":"Curr Biol"},{"key":"10.1016\/j.drudis.2024.104056_b0135","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/cr.2017.144","article-title":"Structural and functional analyses of the mammalian TIN2-TPP1-TRF2 telomeric complex","volume":"27","author":"Hu","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.drudis.2024.104056_b0140","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.crci.2005.06.016","article-title":"NMR studies of telomeric nucleoprotein complexes involving the Myb-like domain of the human telomeric protein TRF2","volume":"9","author":"Bilbille","year":"2006","journal-title":"C R Chim"},{"key":"10.1016\/j.drudis.2024.104056_b0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nsmb.1974","article-title":"A conserved motif within RAP1 has diversified roles in telomere protection and regulation in different organisms","volume":"18","author":"Chen","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.drudis.2024.104056_b0150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1021\/acs.jmedchem.5b01465","article-title":"Design of high-affinity stapled peptides to target the repressor activator protein 1 (RAP1)\/telomeric repeat-binding factor 2 (TRF2) protein\u2013protein interaction in the shelterin complex","volume":"59","author":"Ran","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2024.104056_b0155","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/nsmb867","article-title":"Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection","volume":"11","author":"Lei","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.drudis.2024.104056_b0160","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature05454","article-title":"The POT1-TPP1 telomere complex is a telomerase processivity factor","volume":"445","author":"Wang","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.104056_b0165","doi-asserted-by":"crossref","first-page":"14928","DOI":"10.1038\/ncomms14928","article-title":"Structural and functional analysis of the human POT1\u2013TPP1 telomeric complex","volume":"8","author":"Rice","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2024.104056_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101080","article-title":"Structure, dynamics, and regulation of TRF1-TIN2-mediated trans- and cis-interactions on telomeric DNA","volume":"297","author":"Pan","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2024.104056_b0175","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature05469","article-title":"TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase","volume":"445","author":"Xin","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.104056_b0180","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2012.07.012","article-title":"TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends","volume":"150","author":"Zhong","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2024.104056_b0185","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cell.2020.12.028","article-title":"Telomeres: history, health, and hallmarks of aging","volume":"184","author":"Chakravarti","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2024.104056_b0190","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949076","article-title":"Human RAP1 specifically protects telomeres of senescent cells from DNA damage","volume":"21","author":"Lototska","year":"2020","journal-title":"EMBO Rep"},{"key":"10.1016\/j.drudis.2024.104056_b0195","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201847181","article-title":"Shelterin and subtelomeric DNA sequences control nucleosome maintenance and genome stability","volume":"20","author":"van Emden","year":"2019","journal-title":"EMBO Rep"},{"key":"10.1016\/j.drudis.2024.104056_b0200","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3892\/or.2021.8135","article-title":"Abnormal function of telomere protein TRF2 induces cell mutation and the effects of environmental tumor-promoting factors","volume":"46","author":"Wang","year":"2021","journal-title":"Oncol Rep"},{"key":"10.1016\/j.drudis.2024.104056_b0205","doi-asserted-by":"crossref","first-page":"16830","DOI":"10.3390\/ijms242316830","article-title":"The altered functions of shelterin components in ALT cells","volume":"24","author":"Zhang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.104056_b0210","doi-asserted-by":"crossref","first-page":"25442","DOI":"10.18632\/oncotarget.16036","article-title":"Integrated analysis of promoter methylation and expression of telomere related genes in breast cancer","volume":"8","author":"Heng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2024.104056_b0215","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/gerona\/glu019","article-title":"Targeting of DNA damage signaling pathway induced senescence and reduced migration of cancer cells","volume":"70","author":"Gao","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.drudis.2024.104056_b0220","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10549-010-0988-7","article-title":"Elevated TRF2 in advanced breast cancers with short telomeres","volume":"127","author":"Diehl","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.drudis.2024.104056_b0225","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1038\/cddiscovery.2015.7","article-title":"Rap1-mediated nuclear factor-kappaB (NF-\u03baB) activity regulates the paracrine capacity of mesenchymal stem cells in heart repair following infarction","volume":"1","author":"Zhang","year":"2015","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.drudis.2024.104056_b0230","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1158\/1078-0432.CCR-10-0142","article-title":"Telomere maintenance and DNA damage responses during lung carcinogenesis","volume":"16","author":"Lantuejoul","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.drudis.2024.104056_b0235","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.celrep.2014.09.038","article-title":"The telomeric protein TRF2 regulates angiogenesis by binding and activating the PDGFR\u03b2 promoter","volume":"9","author":"El Ma\u00ef","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.drudis.2024.104056_b0240","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00432-010-0795-x","article-title":"Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer","volume":"136","author":"Hu","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.drudis.2024.104056_b0245","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ijc.23376","article-title":"Telomeric 3\u2019 overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma","volume":"123","author":"Lee","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.drudis.2024.104056_b0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064296","article-title":"Telomere length modulation in human astroglial brain tumors","volume":"8","author":"La Torre","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2024.104056_b0255","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/ijc.22026","article-title":"Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia","volume":"119","author":"Bellon","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.drudis.2024.104056_b0260","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1182\/blood-2007-09-111245","article-title":"Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia","volume":"111","author":"Poncet","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2024.104056_b0265","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.leu.2404141","article-title":"hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia","volume":"20","author":"Campbell","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.drudis.2024.104056_b0270","first-page":"1105","article-title":"Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung","volume":"9","author":"Nakanishi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.drudis.2024.104056_b0275","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1054\/bjoc.2001.1954","article-title":"Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells","volume":"85","author":"Yajima","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.drudis.2024.104056_b0280","doi-asserted-by":"crossref","first-page":"e0115651","DOI":"10.1371\/journal.pone.0115651","article-title":"Over-expression of telomere binding factors (TRF1 & TRF2) in renal cell carcinoma and their inhibition by using SiRNA induce apoptosis, reduce cell proliferation and migration invitro","volume":"10","author":"Pal","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2024.104056_b0285","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41389-018-0062-6","article-title":"p38 MAPK pathway and its interaction with TRF2 in cisplatin induced chemotherapeutic response in head and neck cancer","volume":"7","author":"Roy","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.drudis.2024.104056_b0290","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/v9070164","article-title":"LMP1 and dynamic progressive telomere dysfunction: a major culprit in EBV-associated Hodgkin\u2019s lymphoma","volume":"9","author":"Knecht","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2024.104056_b0295","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ng1633","article-title":"XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer","volume":"37","author":"Mu\u00f1oz","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.drudis.2024.104056_b0300","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/thy.2011.0109","article-title":"Lack of mutations of the telomerase RNA component in familial papillary thyroid cancer with short telomeres","volume":"22","author":"Cantara","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.drudis.2024.104056_b0305","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2141.2008.07176.x","article-title":"Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes","volume":"142","author":"Vega","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.drudis.2024.104056_b0310","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2119\/molmed.2010.00057","article-title":"Altered mRNA expression of telomere-associated genes in monoclonal gammopathy of undetermined significance and multiple myeloma","volume":"16","author":"Panero","year":"2010","journal-title":"Mol Med"},{"key":"10.1016\/j.drudis.2024.104056_b0315","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3390\/cancers12071901","article-title":"Role of telomeres and telomeric proteins in human malignancies and their therapeutic potential","volume":"12","author":"Fernandes","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.drudis.2024.104056_b0320","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1021\/acs.accounts.2c00337","article-title":"DNA G-quadruplex in human telomeres and oncogene promoters: structures, functions, and small molecule targeting","volume":"55","author":"Chen","year":"2022","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.drudis.2024.104056_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103808","article-title":"Harnessing G-quadruplex ligands for lung cancer treatment: a comprehensive overview","volume":"28","author":"Figueiredo","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2024.104056_b0330","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/nar\/gkl1057","article-title":"G-quadruplexes in promoters throughout the human genome","volume":"35","author":"Huppert","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.104056_b0335","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1098\/rstb.2010.0291","article-title":"Telomeres in cancer and ageing","volume":"366","author":"Donate","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.drudis.2024.104056_b0340","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1021\/jacs.3c02783","article-title":"Telomere targeting chimera enables targeted destruction of telomeric repeat-binding factor proteins","volume":"145","author":"Wang","year":"2023","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2024.104056_b0345","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/1087057106296679","article-title":"High-throughput determination of mode of inhibition in lead identification and optimization","volume":"12","author":"Wei","year":"2007","journal-title":"SLAS Discov"},{"key":"10.1016\/j.drudis.2024.104056_b0350","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/cem.2658","article-title":"Rating high-throughput screening results via h-index","volume":"28","author":"Hagiwara","year":"2014","journal-title":"J Chemom"},{"key":"10.1016\/j.drudis.2024.104056_b0355","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00018-019-03369-x","article-title":"Structural biology of telomeres and telomerase","volume":"77","author":"Smith","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.drudis.2024.104056_b0360","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41580-021-00328-y","article-title":"Shaping human telomeres: from shelterin and CST complexes to telomeric chromatin organization","volume":"22","author":"Lim","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2024.104056_b0365","doi-asserted-by":"crossref","first-page":"16708","DOI":"10.1021\/ja5080773","article-title":"Shading the TRF2 recruiting function: a new horizon in drug development","volume":"136","author":"Di Maro","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2024.104056_b0370","doi-asserted-by":"crossref","first-page":"930","DOI":"10.15252\/emmm.201404497","article-title":"Therapeutic inhibition of TRF1 impairs the growth of p53-deficient K-RasG12V-induced lung cancer by induction of telomeric DNA damage","volume":"7","author":"Garc\u00eda-Beccaria","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.drudis.2024.104056_b0375","article-title":"Modified peptide molecules as potential modulators of shelterin protein functions; TRF1","volume":"29","author":"Brankiewicz","year":"2023","journal-title":"Chemistry"},{"key":"10.1016\/j.drudis.2024.104056_b0380","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1021\/acsmedchemlett.8b00152","article-title":"Cyclic peptidic mimetics of apollo peptides targeting telomeric repeat binding factor 2 (TRF2) and Apollo interaction","volume":"9","author":"Chen","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.drudis.2024.104056_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127401","article-title":"N-terminal modified cyclopeptidic mimetics of ApolloTBM as inhibitors of TRF2","volume":"30","author":"Chen","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2024.104056_b0390","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1158\/2159-8290.CD-14-0609","article-title":"Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2\u2019-deoxyguanosine","volume":"5","author":"Mender","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.drudis.2024.104056_b0395","series-title":"Inhibitors of interactions between TRF1-TIN2 or TRF2\u2013TIN2 telomeric proteins for use in anticancer therapy","author":"Brankiewicz","year":"2023"},{"key":"10.1016\/j.drudis.2024.104056_b0400","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.3390\/cancers13122998","article-title":"A novel screen for expression regulators of the telomeric protein TRF2 identified small molecules that impair TRF2 dependent immunosuppression and tumor growth","volume":"13","author":"El Ma\u00ef","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drudis.2024.104056_b0405","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910292","article-title":"Multiple cancer pathways regulate telomere protection","volume":"11","author":"Bejarano","year":"2019","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.drudis.2024.104056_b0410","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.chembiol.2023.11.008","article-title":"Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells","volume":"30","author":"Sobinoff","year":"2023","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.drudis.2024.104056_b0415","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4161\/cbt.6.8.4381","article-title":"Telomere attrition, and chromosome instability via downregulation of TRF2 contributes to arsenic trioxide-induced apoptosis of human T-cell leukemia cell line molt-4 cells","volume":"6","author":"Jiao","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.drudis.2024.104056_b0420","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.bbrc.2012.02.063","article-title":"Interaction of Berberine derivative with protein POT1 affect telomere function in cancer cells","volume":"419","author":"Xiao","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.drudis.2024.104056_b0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245675","article-title":"POT1 stability and binding measured by fluorescence thermal shift assays","volume":"16","author":"DeLeeuw","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2024.104056_b0430","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.bbapap.2017.08.022","article-title":"Curcusone C induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2","volume":"1865","author":"Wang","year":"2017","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"10.1016\/j.drudis.2024.104056_b0435","series-title":"Modulation of TRF1 for brain cancer treatment","author":"Blasco Marhuenda","year":"2022"},{"key":"10.1016\/j.drudis.2024.104056_b0440","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/em.22295","article-title":"Epigallocatechin-3-gallate induces telomere shortening and clastogenic damage in glioblastoma cells","volume":"60","author":"Udroiu","year":"2019","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.drudis.2024.104056_b0445","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41401-024-01243-6","article-title":"Discovery of a selective TRF2 inhibitor FKB04 induced telomere shortening and senescence in liver cancer cells","volume":"45","author":"Qiu","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.drudis.2024.104056_b0450","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216033","article-title":"MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer","volume":"15","author":"Dinami","year":"2023","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.drudis.2024.104056_b0455","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1021\/ac052218f","article-title":"Verification of antiparallel G-quadruplex structure in human telomeres by using two-photon excitation fluorescence lifetime imaging microscopy of the 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide molecule","volume":"78","author":"Chang","year":"2006","journal-title":"Anal Chem"},{"key":"10.1016\/j.drudis.2024.104056_b0460","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1124\/mol.104.001537","article-title":"Biological activity of the g-quadruplex ligand RHPS4 (3,11-Difluoro-6,8,13-trimethyl-8H-quinoacridinium methosulfate) is associated with telomere capping alteration","volume":"66","author":"Leonetti","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.drudis.2024.104056_b0465","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ejca.2006.03.010","article-title":"TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells","volume":"42","author":"Biroccio","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.drudis.2024.104056_b0470","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1172\/JCI32461","article-title":"Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect","volume":"117","author":"Salvati","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2024.104056_b0475","doi-asserted-by":"crossref","first-page":"38837","DOI":"10.1074\/jbc.M106779200","article-title":"Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening","volume":"276","author":"Grozinger","year":"2001","journal-title":"JBC"},{"key":"10.1016\/j.drudis.2024.104056_b0480","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1080\/07391102.2019.1682052","article-title":"Virtual high-throughput screening of natural compounds in-search of potential inhibitors for protection of telomeres 1 (POT1)","volume":"38","author":"Amir","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.drudis.2024.104056_b0485","doi-asserted-by":"crossref","first-page":"1112831","DOI":"10.3389\/fsysb.2023.1112831","article-title":"Flobak \u00c5 Synergistic effects of complex drug combinations in colorectal cancer cells predicted by logical modelling","volume":"3","author":"Folkesson","year":"2023","journal-title":"Front Syst Biol"},{"key":"10.1016\/j.drudis.2024.104056_b0490","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.isci.2019.08.012","article-title":"Safety of whole-body abrogation of the TRF1 shelterin protein in wild-type and cancer-prone mouse models","volume":"19","author":"Bejarano","year":"2019","journal-title":"iScience"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624001818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624001818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T17:11:06Z","timestamp":1722618666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644624001818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":98,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1359644624001818"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2024.104056","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting shelterin proteins for cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2024.104056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104056"}}